John G. Ullman & Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$4.6M |
| 2 |
Lowe's Companies
LOW
|
+$4.54M |
| 3 |
Generac Holdings
GNRC
|
+$4.05M |
| 4 |
Zimmer Biomet
ZBH
|
+$3.64M |
| 5 |
Chewy
CHWY
|
+$2.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$9.11M |
| 2 |
VMW
VMware, Inc
VMW
|
+$6.88M |
| 3 |
Aecom
ACM
|
+$6.65M |
| 4 |
Pfizer
PFE
|
+$5.11M |
| 5 |
Black Hills Corp
BKH
|
+$4.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.19% |
| 2 | Healthcare | 17.08% |
| 3 | Industrials | 16.64% |
| 4 | Utilities | 9.87% |
| 5 | Energy | 6.31% |
Similar funds
John G. Ullman & Associates's Q4 2023 Portfolio in Review
As of Q4 2023, John G. Ullman & Associates held 186 positions worth $630M, up 3.1% from $611M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
John G. Ullman & Associates withdrew a net $22.7M in Q4 2023, closing 17 positions and reducing 79 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $9.11M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John G. Ullman & Associates opened a new position in Lowe's Companies worth $4.98M.
- John G. Ullman & Associates's largest Q4 2023 buy was Lowe's Companies: 22,375 shares worth $4.98M.
- John G. Ullman & Associates added most to Broadcom in Q4 2023, an estimated $4.6M increase.
- John G. Ullman & Associates's biggest Q4 2023 reduction was Aecom, cutting an estimated $6.65M.
- John G. Ullman & Associates fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $9.11M.
- John G. Ullman & Associates's ten largest holdings make up 32% of its $630M portfolio in Q4 2023.
- John G. Ullman & Associates opened 13 new positions and closed 17 in Q4 2023.
- John G. Ullman & Associates's portfolio value rose 3.1% quarter-over-quarter to $630M.
Based on John G. Ullman & Associates's 13F filing for Q4 2023, filed 31 Jan 2024.